Skip to content
2000
Volume 19, Issue 2
  • ISSN: 1573-4013
  • E-ISSN: 2212-3881

Abstract

Different formulations of ashwagandha have been utilized for the treatment of neurological disorders. The present manuscript aimed to discuss various roles of Withania somnifera, (ashwagandha) in the treatment of neurological disorders. In the literature, several neuroprotective phytoconstituents of ashwagandha have been reported, with important pharmacological effects on neurological and brain disorders such as anxiety, Alzheimer's, Parkinson's, and Schizophrenia. Preclinical studies, clinical trials, and patents indicate that Withania somnifera has a wide range of potential as a neuroprotective in several neurological disorders. After a complete literature survey, it can be concluded that Withania somnifera has significant potential to treat neurological disorders.

Loading

Article metrics loading...

/content/journals/cnf/10.2174/1573401318666220415084108
2023-02-01
2024-10-15
Loading full text...

Full text loading...

/content/journals/cnf/10.2174/1573401318666220415084108
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test